NET led to a decrease in tumor Ki-67-positivity in 74.3% of cases [median decrease of 3.14 percentage points (range 0.22–37.8)] and an increase in 25.7% of tumors [median increase of 1.29 percentage points (range 0.37–5.32)]. This evidence concerns the gene MKI67 and neoplasm.